MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients
Clinical trial NCT01264874 · TERMINATED
Trial details
- NCT number
- NCT01264874
- Sponsor
- European Institute of Oncology
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2017-07-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.